<?xml version="1.0" encoding="UTF-8"?>

<Bundle xmlns="http://hl7.org/fhir">
  <id value="enchanced-bundledovato-pedro-es"/>
  <meta>
    <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Bundle-uv-epi"/>
  </meta>
  <language value="en"/>
  <identifier>
    <system value="https://www.gravitatehealth.eu/sid/doc"/>
    <value value="EU/1/97/049/001"/>
  </identifier>
  <type value="document"/>
  <timestamp value="2023-04-25T11:55:27Z"/>
  <entry>
    <fullUrl value="http://hl7.eu/fhir/ig/gravitate-health/Composition/compositione722f6782d3f34f86982e14386c8811dhh"/>
    <resource>
      <Composition>
        <id value="compositione722f6782d3f34f86982e14386c8811dhh"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Composition-uv-epi"/>
        </meta>
        <language value="es"/>
        <text>
          <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml" xml:lang="es" lang="es"><p><b>Generated Narrative: Composition</b><a name="compositione722f6782d3f34f86982e14386c8811dhh"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Composition &quot;compositione722f6782d3f34f86982e14386c8811dhh&quot;  (Language &quot;es&quot;) </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info//StructureDefinition-Composition-uv-epi.html">Composition (ePI)</a></p></div><p><b>identifier</b>: id: yy</p><p><b>status</b>: final</p><p><b>type</b>: Package Leaflet <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (#100000155538)</span></p><p><b>date</b>: 2022-04-29 13:28:17+0000</p><p><b>author</b>: <a href="#Organization_mra-7c9b97127f73ff3605a10eb1c2cc24d1">See above (Organization/mra-7c9b97127f73ff3605a10eb1c2cc24d1)</a></p><p><b>title</b>: TEST PURPOSES ONLY - Dovato 50 mg/300 mg comprimidos recubiertos con película</p><h3>Attesters</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Mode</b></td><td><b>Time</b></td></tr><tr><td style="display: none">*</td><td>Official <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-composition-attestation-mode.html">Composition Attestation Mode</a>#official)</span></td><td>2022-04-29 13:28:17+0000</td></tr></table></div>
        </text>
        <identifier>
          <system value="https://spor.ema.europa.eu/rmswi/"/>
          <value value="yy"/>
        </identifier>
        <status value="final"/>
        <type>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi/"/>
            <code value="100000155538"/>
          </coding>
          <text value="Package Leaflet"/>
        </type>
        <subject>
          <reference value="MedicinalProductDefinition/mp16598f252d07b4784b82ba43cf9e847e"/>
        </subject>
        <date value="2022-04-29T13:28:17Z"/>
        <author>
          <reference value="Organization/mra-7c9b97127f73ff3605a10eb1c2cc24d1"/>
        </author>
        <title value="TEST PURPOSES ONLY - Dovato 50 mg/300 mg comprimidos recubiertos con película"/>
        <attester>
          <mode>
            <coding>
              <system value="http://hl7.org/fhir/composition-attestation-mode"/>
              <code value="official"/>
            </coding>
          </mode>
          <time value="2022-04-29T13:28:17Z"/>
        </attester>
        <section>
          <title value="B. Package Leaflet"/>
          <code>
            <coding>
              <system value="https://spor.ema.europa.eu/rmswi/"/>
              <code value="100000155538"/>
            </coding>
            <text value="B. PACKAGE LEAFLET"/>
          </code>
          <text>
            <status value="additional"/><div xmlns="http://www.w3.org/1999/xhtml">unavailable</div>
          </text>
          <emptyReason>
            <coding>
              <system value="http://terminology.hl7.org/CodeSystem/list-empty-reason"/>
              <code value="unavailable"/>
            </coding>
          </emptyReason>
          <section>
            <title value="Package leaflet: Information for the user"/>
            <code>
              <coding>
                <system value="https://spor.ema.europa.eu/rmswi/"/>
                <code value="100000155538"/>
              </coding>
              <text value="Package leaflet: Information for the user"/>
            </code>
            <text>
              <status value="additional"/><div xmlns="http://www.w3.org/1999/xhtml">Prospecto: información para el paciente Dovato 50 mg/300 mg comprimidos recubiertos con película dolutegravir/lamivudina <b>Lea todo el prospecto detenidamente antes de empezar a tomar este medicamento, porque contiene información importante para usted.</b><ul><li>Conserve este prospecto, ya que puede tener que volver a leerlo.</li><li>Si tiene alguna duda, consulte a su médico o farmacéutico.</li><li>Este medicamento se le ha recetado solamente a usted, y no debe dárselo a otras personas aunque tengan los mismos síntomas que usted, ya que puede perjudicarles.</li><li>Si experimenta efectos adversos, consulte a su médico o farmacéutico, incluso si se trata de efectos adversos que no aparecen en este prospecto. Ver sección 4.</li></ul></div>
            </text>
          </section>
          <section>
            <title value="What is in this leaflet"/>
            <code>
              <coding>
                <system value="https://spor.ema.europa.eu/rmswi/"/>
                <code value="100000155538"/>
              </coding>
              <text value="What is in this leaflet"/>
            </code>
            <text>
              <status value="additional"/><div xmlns="http://www.w3.org/1999/xhtml">Contenido del prospecto<ol><li>Qué es Dovato y para qué se utiliza</li><li>Qué necesita saber antes de empezar a tomar Dovato</li><li>Cómo tomar Dovato</li><li>Posibles efectos adversos</li><li>Conservación de Dovato</li><li>Contenido del envase e información adicional</li></ol></div>
            </text>
          </section>
          <section>
            <title value="1. What Dovato 50 mg/300 mg comprimidos recubiertos con película is and what it is used for"/>
            <code>
              <coding>
                <system value="https://spor.ema.europa.eu/rmswi/"/>
                <code value="100000155538"/>
              </coding>
              <text value="1. What Dovato 50 mg/300 mg comprimidos recubiertos con película is and what it is used for"/>
            </code>
            <text>
              <status value="additional"/><div xmlns="http://www.w3.org/1999/xhtml"><b>1. Qué es Dovato y para qué se utiliza</b> Dovato es un medicamento que contiene dos principios activos usados para tratar la infección por el virus de la inmunodeficiencia humana (VIH): dolutegravir y lamivudina. Dolutegravir pertenece al grupo de medicamentos antirretrovirales llamados inhibidores de la integrasa (INI) y lamivudina pertenece a un grupo de medicamentos antirretrovirales denominados inhibidores de la transcriptasa inversa análogos de nucleósido (ITIAN).</div>
            </text>
          </section>
          <section>
            <title value="2. What you need to know before you take Dovato 50 mg/300 mg comprimidos recubiertos con película"/>
            <code>
              <coding>
                <system value="https://spor.ema.europa.eu/rmswi/"/>
                <code value="100000155538"/>
              </coding>
              <text value="2. What you need to know before you take Dovato 50 mg/300 mg comprimidos recubiertos con película"/>
            </code>
            <text>
              <status value="additional"/><div xmlns="http://www.w3.org/1999/xhtml"><b>2. Qué necesita saber antes de empezar a tomar Dovato</b> <b>No tome Dovato</b><ul><li>si es <b>alérgico</b> (hipersensible) a dolutegravir o lamivudina o a alguno de los demás componentes de este medicamento (incluidos en la sección 6)</li><li>si está tomando un medicamento llamado <b>fampridina</b> (también conocido como dalfampridina; utilizado para tratar la esclerosis múltiple).</li></ul></div>
            </text>
          </section>
          <section>
            <title value="3. How to take Dovato 50 mg/300 mg comprimidos recubiertos con película"/>
            <code>
              <coding>
                <system value="https://spor.ema.europa.eu/rmswi/"/>
                <code value="100000155538"/>
              </coding>
              <text value="3. How to take Dovato 50 mg/300 mg comprimidos recubiertos con película"/>
            </code>
            <text>
              <status value="additional"/><div xmlns="http://www.w3.org/1999/xhtml"><b>3. Cómo tomar Dovato</b><p>Siga exactamente las instrucciones de administración de este medicamento indicadas por su médico. En caso de duda, consulte de nuevo a su médico o farmacéutico.</p><ul><li>La dosis recomendada de Dovato es <b>un comprimido una vez al día.</b></li></ul><p>Trague el comprimido con un poco de líquido. Dovato se puede tomar con o sin alimentos.</p></div>
            </text>
          </section>
          <section>
            <title value="4. Possible side effects"/>
            <code>
              <coding>
                <system value="https://spor.ema.europa.eu/rmswi/"/>
                <code value="100000155538"/>
              </coding>
              <text value="4. Possible side effects"/>
            </code>
            <text>
              <status value="additional"/><div xmlns="http://www.w3.org/1999/xhtml"><p><b>4. Posibles efectos adversos</b></p><p>Al igual que todos los medicamentos, este medicamento puede producir efectos adversos, aunque no todas las personas los sufran, <b>por lo que es muy importante que le comente a su médico cualquier cambio en su estado de salud.</b></p></div>
            </text>
          </section>
          <section>
            <title value="5. How to store Dovato 50 mg/300 mg comprimidos recubiertos con película"/>
            <code>
              <coding>
                <system value="https://spor.ema.europa.eu/rmswi/"/>
                <code value="100000155538"/>
              </coding>
              <text value="5. How to store Dovato 50 mg/300 mg comprimidos recubiertos con película"/>
            </code>
            <text>
              <status value="additional"/><div xmlns="http://www.w3.org/1999/xhtml"><b>5. Conservación de Dovato</b><p>Mantener este medicamento fuera de la vista y del alcance de los niños</p><p>No utilice este medicamento después de la fecha de caducidad que aparece en la caja y el frasco después de CAD. La fecha de caducidad es el último día del mes que se indica.</p><p>Este medicamento no requiere ninguna condición especial de conservación.</p><p>Los medicamentos no se deben tirar por los desagües ni a la basura. Pregunte a su farmacéutico cómo deshacerse de los envases y de los medicamentos que ya no necesita. De esta forma, ayudará a proteger el medio ambiente.</p></div>
            </text>
          </section>
          <section>
            <title value="6. Contents of the pack and other information"/>
            <code>
              <coding>
                <system value="https://spor.ema.europa.eu/rmswi/"/>
                <code value="100000155538"/>
              </coding>
              <text value="6. Contents of the pack and other information"/>
            </code>
            <text>
              <status value="additional"/><div xmlns="http://www.w3.org/1999/xhtml"><b>6. Contenido del envase e información adicional</b> <b>Composición de Dovato</b><ul><li>Los principios activos son dolutegravir y lamivudina. Cada comprimido contiene dolutegravir sódico equivalente a 50 mg de dolutegravir y 300 mg de lamivudina.</li><li>Los demás componentes son celulosa microcristalina, carboximetilalmidón sódico, estearato de magnesio, manitol (E421), povidona (K29/32), fumarato estearilo de sodio, hipromelosa (E464), macrogol, dióxido de titanio (E171).</li><li>Este medicamento contiene menos de 1 mmol de sodio (23 mg) por comprimido; esto es, esencialmente “exento de sodio”.</li></ul></div>
            </text>
          </section>
        </section>
      </Composition>
    </resource>
  </entry>
  <entry>
    <fullUrl value="http://hl7.eu/fhir/ig/gravitate-health/Ingredient/ingredient-for-dovato-dolutegravirsodium"/>
    <resource>
      <Ingredient>
        <id value="ingredient-for-dovato-dolutegravirsodium"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
        </meta>
        <text>
          <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: Ingredient</b><a name="ingredient-for-dovato-dolutegravirsodium"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Ingredient &quot;ingredient-for-dovato-dolutegravirsodium&quot; </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info//StructureDefinition-Ingredient-uv-epi.html">Ingredient (ePI)</a></p></div><p><b>identifier</b>: id: 1Q1V9V5WYQ (use: OFFICIAL)</p><p><b>status</b>: active</p><p><b>for</b>: </p><ul><li><a href="#ManufacturedItemDefinition_mid-49178f16170ee8a6bc2a4361c1748d5f">See above (ManufacturedItemDefinition/mid-49178f16170ee8a6bc2a4361c1748d5f)</a></li><li><a href="#MedicinalProductDefinition_mp16598f252d07b4784b82ba43cf9e847e">See above (MedicinalProductDefinition/mp16598f252d07b4784b82ba43cf9e847e)</a></li><li><a href="#AdministrableProductDefinition_ap-49178f16170ee8a6bc2a4361c1748d5f">See above (AdministrableProductDefinition/ap-49178f16170ee8a6bc2a4361c1748d5f)</a></li></ul><p><b>role</b>: active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#72072)</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td>DOLUTEGRAVIR SODIUM <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#1Q1V9V5WYQ)</span></td></tr></table><h3>Strengths</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Presentation[x]</b></td><td><b>Basis</b></td></tr><tr><td style="display: none">*</td><td>50 mg<span style="background: LightGoldenRodYellow"> (Details: UCUM code mg = 'mg')</span></td><td>active ingredient - basis of strength <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-v3-RoleClass.html">RoleClass</a>#ACTIB)</span></td></tr></table></blockquote></div>
        </text>
        <identifier>
          <use value="official"/>
          <system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
          <value value="1Q1V9V5WYQ"/>
        </identifier>
        <status value="active"/>
        <for>
          <reference value="ManufacturedItemDefinition/mid-49178f16170ee8a6bc2a4361c1748d5f"/>
        </for>
        <for>
          <reference value="MedicinalProductDefinition/mp16598f252d07b4784b82ba43cf9e847e"/>
        </for>
        <for>
          <reference value="AdministrableProductDefinition/ap-49178f16170ee8a6bc2a4361c1748d5f"/>
        </for>
        <role>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi"/>
            <code value="72072"/>
            <display value="active"/>
          </coding>
        </role>
        <substance>
          <code>
            <concept>
              <coding>
                <system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
                <code value="1Q1V9V5WYQ"/>
                <display value="DOLUTEGRAVIR SODIUM"/>
              </coding>
            </concept>
          </code>
          <strength>
            <presentationQuantity>
              <value value="50"/>
              <system value="http://unitsofmeasure.org"/>
              <code value="mg"/>
            </presentationQuantity>
            <basis>
              <coding>
                <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass"/>
                <code value="ACTIB"/>
                <display value="active ingredient - basis of strength"/>
              </coding>
            </basis>
          </strength>
        </substance>
      </Ingredient>
    </resource>
  </entry>
  <entry>
    <fullUrl value="http://hl7.eu/fhir/ig/gravitate-health/Ingredient/ingredient-for-dovato-lamivudine"/>
    <resource>
      <Ingredient>
        <id value="ingredient-for-dovato-lamivudine"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
        </meta>
        <text>
          <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: Ingredient</b><a name="ingredient-for-dovato-lamivudine"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Ingredient &quot;ingredient-for-dovato-lamivudine&quot; </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info//StructureDefinition-Ingredient-uv-epi.html">Ingredient (ePI)</a></p></div><p><b>identifier</b>: id: 2T8Q726O95 (use: OFFICIAL)</p><p><b>status</b>: active</p><p><b>for</b>: </p><ul><li><a href="#ManufacturedItemDefinition_mid-49178f16170ee8a6bc2a4361c1748d5f">See above (ManufacturedItemDefinition/mid-49178f16170ee8a6bc2a4361c1748d5f)</a></li><li><a href="#MedicinalProductDefinition_mp16598f252d07b4784b82ba43cf9e847e">See above (MedicinalProductDefinition/mp16598f252d07b4784b82ba43cf9e847e)</a></li><li><a href="#AdministrableProductDefinition_ap-49178f16170ee8a6bc2a4361c1748d5f">See above (AdministrableProductDefinition/ap-49178f16170ee8a6bc2a4361c1748d5f)</a></li></ul><p><b>role</b>: active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#72072)</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td>lamivudine <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#2T8Q726O95)</span></td></tr></table><h3>Strengths</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Presentation[x]</b></td><td><b>Basis</b></td></tr><tr><td style="display: none">*</td><td>300 mg<span style="background: LightGoldenRodYellow"> (Details: UCUM code mg = 'mg')</span></td><td>active ingredient - basis of strength <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-v3-RoleClass.html">RoleClass</a>#ACTIB)</span></td></tr></table></blockquote></div>
        </text>
        <identifier>
          <use value="official"/>
          <system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
          <value value="2T8Q726O95"/>
        </identifier>
        <status value="active"/>
        <for>
          <reference value="ManufacturedItemDefinition/mid-49178f16170ee8a6bc2a4361c1748d5f"/>
        </for>
        <for>
          <reference value="MedicinalProductDefinition/mp16598f252d07b4784b82ba43cf9e847e"/>
        </for>
        <for>
          <reference value="AdministrableProductDefinition/ap-49178f16170ee8a6bc2a4361c1748d5f"/>
        </for>
        <role>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi"/>
            <code value="72072"/>
            <display value="active"/>
          </coding>
        </role>
        <substance>
          <code>
            <concept>
              <coding>
                <system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
                <code value="2T8Q726O95"/>
                <display value="lamivudine"/>
              </coding>
            </concept>
          </code>
          <strength>
            <presentationQuantity>
              <value value="300"/>
              <system value="http://unitsofmeasure.org"/>
              <code value="mg"/>
            </presentationQuantity>
            <basis>
              <coding>
                <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass"/>
                <code value="ACTIB"/>
                <display value="active ingredient - basis of strength"/>
              </coding>
            </basis>
          </strength>
        </substance>
      </Ingredient>
    </resource>
  </entry>
  <entry>
    <fullUrl value="http://hl7.eu/fhir/ig/gravitate-health/Ingredient/ingredient-for-dovato-microcrystallinecellulose"/>
    <resource>
      <Ingredient>
        <id value="ingredient-for-dovato-microcrystallinecellulose"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
        </meta>
        <text>
          <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: Ingredient</b><a name="ingredient-for-dovato-microcrystallinecellulose"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Ingredient &quot;ingredient-for-dovato-microcrystallinecellulose&quot; </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info//StructureDefinition-Ingredient-uv-epi.html">Ingredient (ePI)</a></p></div><p><b>identifier</b>: id: OP1R32D61U (use: OFFICIAL)</p><p><b>status</b>: active</p><p><b>for</b>: </p><ul><li><a href="#ManufacturedItemDefinition_mid-49178f16170ee8a6bc2a4361c1748d5f">See above (ManufacturedItemDefinition/mid-49178f16170ee8a6bc2a4361c1748d5f)</a></li><li><a href="#MedicinalProductDefinition_mp16598f252d07b4784b82ba43cf9e847e">See above (MedicinalProductDefinition/mp16598f252d07b4784b82ba43cf9e847e)</a></li><li><a href="#AdministrableProductDefinition_ap-49178f16170ee8a6bc2a4361c1748d5f">See above (AdministrableProductDefinition/ap-49178f16170ee8a6bc2a4361c1748d5f)</a></li></ul><p><b>role</b>: Excipient <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072082)</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td>microcrystalline cellulose <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#OP1R32D61U)</span></td></tr></table></blockquote></div>
        </text>
        <identifier>
          <use value="official"/>
          <system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
          <value value="OP1R32D61U"/>
        </identifier>
        <status value="active"/>
        <for>
          <reference value="ManufacturedItemDefinition/mid-49178f16170ee8a6bc2a4361c1748d5f"/>
        </for>
        <for>
          <reference value="MedicinalProductDefinition/mp16598f252d07b4784b82ba43cf9e847e"/>
        </for>
        <for>
          <reference value="AdministrableProductDefinition/ap-49178f16170ee8a6bc2a4361c1748d5f"/>
        </for>
        <role>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi"/>
            <code value="100000072082"/>
            <display value="Excipient"/>
          </coding>
        </role>
        <substance>
          <code>
            <concept>
              <coding>
                <system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
                <code value="OP1R32D61U"/>
                <display value="microcrystalline cellulose"/>
              </coding>
            </concept>
          </code>
        </substance>
      </Ingredient>
    </resource>
  </entry>
  <entry>
    <fullUrl value="http://hl7.eu/fhir/ig/gravitate-health/Ingredient/ingredient-for-dovato-sodiumstarchglycolate"/>
    <resource>
      <Ingredient>
        <id value="ingredient-for-dovato-sodiumstarchglycolate"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
        </meta>
        <text>
          <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: Ingredient</b><a name="ingredient-for-dovato-sodiumstarchglycolate"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Ingredient &quot;ingredient-for-dovato-sodiumstarchglycolate&quot; </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info//StructureDefinition-Ingredient-uv-epi.html">Ingredient (ePI)</a></p></div><p><b>identifier</b>: id: H8AV0SQX4D (use: OFFICIAL)</p><p><b>status</b>: active</p><p><b>for</b>: </p><ul><li><a href="#ManufacturedItemDefinition_mid-49178f16170ee8a6bc2a4361c1748d5f">See above (ManufacturedItemDefinition/mid-49178f16170ee8a6bc2a4361c1748d5f)</a></li><li><a href="#MedicinalProductDefinition_mp16598f252d07b4784b82ba43cf9e847e">See above (MedicinalProductDefinition/mp16598f252d07b4784b82ba43cf9e847e)</a></li><li><a href="#AdministrableProductDefinition_ap-49178f16170ee8a6bc2a4361c1748d5f">See above (AdministrableProductDefinition/ap-49178f16170ee8a6bc2a4361c1748d5f)</a></li></ul><p><b>role</b>: Excipient <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072082)</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td>sodium starch glycolate <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#H8AV0SQX4D)</span></td></tr></table></blockquote></div>
        </text>
        <identifier>
          <use value="official"/>
          <system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
          <value value="H8AV0SQX4D"/>
        </identifier>
        <status value="active"/>
        <for>
          <reference value="ManufacturedItemDefinition/mid-49178f16170ee8a6bc2a4361c1748d5f"/>
        </for>
        <for>
          <reference value="MedicinalProductDefinition/mp16598f252d07b4784b82ba43cf9e847e"/>
        </for>
        <for>
          <reference value="AdministrableProductDefinition/ap-49178f16170ee8a6bc2a4361c1748d5f"/>
        </for>
        <role>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi"/>
            <code value="100000072082"/>
            <display value="Excipient"/>
          </coding>
        </role>
        <substance>
          <code>
            <concept>
              <coding>
                <system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
                <code value="H8AV0SQX4D"/>
                <display value="sodium starch glycolate"/>
              </coding>
            </concept>
          </code>
        </substance>
      </Ingredient>
    </resource>
  </entry>
  <entry>
    <fullUrl value="http://hl7.eu/fhir/ig/gravitate-health/Ingredient/ingredient-for-dovato-magnesiumstearate"/>
    <resource>
      <Ingredient>
        <id value="ingredient-for-dovato-magnesiumstearate"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
        </meta>
        <text>
          <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: Ingredient</b><a name="ingredient-for-dovato-magnesiumstearate"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Ingredient &quot;ingredient-for-dovato-magnesiumstearate&quot; </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info//StructureDefinition-Ingredient-uv-epi.html">Ingredient (ePI)</a></p></div><p><b>identifier</b>: id: 70097M6I30 (use: OFFICIAL)</p><p><b>status</b>: active</p><p><b>for</b>: </p><ul><li><a href="#ManufacturedItemDefinition_mid-49178f16170ee8a6bc2a4361c1748d5f">See above (ManufacturedItemDefinition/mid-49178f16170ee8a6bc2a4361c1748d5f)</a></li><li><a href="#MedicinalProductDefinition_mp16598f252d07b4784b82ba43cf9e847e">See above (MedicinalProductDefinition/mp16598f252d07b4784b82ba43cf9e847e)</a></li><li><a href="#AdministrableProductDefinition_ap-49178f16170ee8a6bc2a4361c1748d5f">See above (AdministrableProductDefinition/ap-49178f16170ee8a6bc2a4361c1748d5f)</a></li></ul><p><b>role</b>: Excipient <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072082)</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td>magnesium stearate <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#70097M6I30)</span></td></tr></table></blockquote></div>
        </text>
        <identifier>
          <use value="official"/>
          <system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
          <value value="70097M6I30"/>
        </identifier>
        <status value="active"/>
        <for>
          <reference value="ManufacturedItemDefinition/mid-49178f16170ee8a6bc2a4361c1748d5f"/>
        </for>
        <for>
          <reference value="MedicinalProductDefinition/mp16598f252d07b4784b82ba43cf9e847e"/>
        </for>
        <for>
          <reference value="AdministrableProductDefinition/ap-49178f16170ee8a6bc2a4361c1748d5f"/>
        </for>
        <role>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi"/>
            <code value="100000072082"/>
            <display value="Excipient"/>
          </coding>
        </role>
        <substance>
          <code>
            <concept>
              <coding>
                <system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
                <code value="70097M6I30"/>
                <display value="magnesium stearate"/>
              </coding>
            </concept>
          </code>
        </substance>
      </Ingredient>
    </resource>
  </entry>
  <entry>
    <fullUrl value="http://hl7.eu/fhir/ig/gravitate-health/Ingredient/ingredient-for-dovato-mannitol"/>
    <resource>
      <Ingredient>
        <id value="ingredient-for-dovato-mannitol"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
        </meta>
        <text>
          <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: Ingredient</b><a name="ingredient-for-dovato-mannitol"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Ingredient &quot;ingredient-for-dovato-mannitol&quot; </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info//StructureDefinition-Ingredient-uv-epi.html">Ingredient (ePI)</a></p></div><p><b>identifier</b>: id: 3OWL53L36A (use: OFFICIAL)</p><p><b>status</b>: active</p><p><b>for</b>: </p><ul><li><a href="#ManufacturedItemDefinition_mid-49178f16170ee8a6bc2a4361c1748d5f">See above (ManufacturedItemDefinition/mid-49178f16170ee8a6bc2a4361c1748d5f)</a></li><li><a href="#MedicinalProductDefinition_mp16598f252d07b4784b82ba43cf9e847e">See above (MedicinalProductDefinition/mp16598f252d07b4784b82ba43cf9e847e)</a></li><li><a href="#AdministrableProductDefinition_ap-49178f16170ee8a6bc2a4361c1748d5f">See above (AdministrableProductDefinition/ap-49178f16170ee8a6bc2a4361c1748d5f)</a></li></ul><p><b>role</b>: Excipient <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072082)</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td>mannitol <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#3OWL53L36A)</span></td></tr></table></blockquote></div>
        </text>
        <identifier>
          <use value="official"/>
          <system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
          <value value="3OWL53L36A"/>
        </identifier>
        <status value="active"/>
        <for>
          <reference value="ManufacturedItemDefinition/mid-49178f16170ee8a6bc2a4361c1748d5f"/>
        </for>
        <for>
          <reference value="MedicinalProductDefinition/mp16598f252d07b4784b82ba43cf9e847e"/>
        </for>
        <for>
          <reference value="AdministrableProductDefinition/ap-49178f16170ee8a6bc2a4361c1748d5f"/>
        </for>
        <role>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi"/>
            <code value="100000072082"/>
            <display value="Excipient"/>
          </coding>
        </role>
        <substance>
          <code>
            <concept>
              <coding>
                <system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
                <code value="3OWL53L36A"/>
                <display value="mannitol"/>
              </coding>
            </concept>
          </code>
        </substance>
      </Ingredient>
    </resource>
  </entry>
  <entry>
    <fullUrl value="http://hl7.eu/fhir/ig/gravitate-health/SubstanceDefinition/substance-dolutegravirsodium"/>
    <resource>
      <SubstanceDefinition>
        <id value="substance-dolutegravirsodium"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/SubstanceDefinition-uv-epi"/>
        </meta>
        <text>
          <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: SubstanceDefinition</b><a name="substance-dolutegravirsodium"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource SubstanceDefinition &quot;substance-dolutegravirsodium&quot; </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info//StructureDefinition-SubstanceDefinition-uv-epi.html">SubstanceDefinition (ePI)</a></p></div><p><b>identifier</b>: id: 1Q1V9V5WYQ (use: OFFICIAL)</p><p><b>version</b>: 1</p><p><b>status</b>: Active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>manufacturer</b>: <a href="#Organization_man-173fde4cb6b1018cb7ec8ab708d3961c">See above (Organization/man-173fde4cb6b1018cb7ec8ab708d3961c)</a></p><h3>MolecularWeights</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>Amount</b></td></tr><tr><td style="display: none">*</td><td>exact <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> ()</span></td><td>441.36</td></tr></table><h3>Structures</h3><table class="grid"><tr><td style="display: none">-</td><td><b>MolecularFormula</b></td></tr><tr><td style="display: none">*</td><td>C20H18F2N305.Na</td></tr></table><h3>Names</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Name</b></td><td><b>Type</b></td></tr><tr><td style="display: none">*</td><td>(4R,12.ALPHA.S)-N-((2,4-DIFLUOROPHENYL)METHYL)-7-HYDROXY-4-METHYL-6,8-DIOXO-3,4,6,8,12,12.ALPHA.-HEXAHYDRO-2H-PYRIDO(1',2':4,5)PYRAZINO(2,1-.BETA.)(1,3)OXAZINE-9-CARBOXAMIDE</td><td>Chemical Name <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (#x)</span></td></tr></table></div>
        </text>
        <identifier>
          <use value="official"/>
          <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
          <value value="1Q1V9V5WYQ"/>
        </identifier>
        <version value="1"/>
        <status>
          <coding>
            <system value="http://hl7.org/fhir/publication-status"/>
            <code value="active"/>
          </coding>
        </status>
        <manufacturer>
          <reference value="Organization/man-173fde4cb6b1018cb7ec8ab708d3961c"/>
        </manufacturer>
        <molecularWeight>
          <type>
            <text value="exact"/>
          </type>
          <amount>
            <value value="441.36"/>
          </amount>
        </molecularWeight>
        <structure>
          <molecularFormula value="C20H18F2N305.Na"/>
        </structure>
        <name>
          <name value="(4R,12.ALPHA.S)-N-((2,4-DIFLUOROPHENYL)METHYL)-7-HYDROXY-4-METHYL-6,8-DIOXO-3,4,6,8,12,12.ALPHA.-HEXAHYDRO-2H-PYRIDO(1',2':4,5)PYRAZINO(2,1-.BETA.)(1,3)OXAZINE-9-CARBOXAMIDE"/>
          <type>
            <coding>
              <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
              <code value="x"/>
              <display value="Chemical Name"/>
            </coding>
          </type>
        </name>
      </SubstanceDefinition>
    </resource>
  </entry>
  <entry>
    <fullUrl value="http://hl7.eu/fhir/ig/gravitate-health/SubstanceDefinition/substance-lamivudine"/>
    <resource>
      <SubstanceDefinition>
        <id value="substance-lamivudine"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/SubstanceDefinition-uv-epi"/>
        </meta>
        <text>
          <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: SubstanceDefinition</b><a name="substance-lamivudine"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource SubstanceDefinition &quot;substance-lamivudine&quot; </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info//StructureDefinition-SubstanceDefinition-uv-epi.html">SubstanceDefinition (ePI)</a></p></div><p><b>identifier</b>: id: 2T8Q726O95 (use: OFFICIAL)</p><p><b>version</b>: 1</p><p><b>status</b>: Active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>manufacturer</b>: <a href="#Organization_man-173fde4cb6b1018cb7ec8ab708d3961c">See above (Organization/man-173fde4cb6b1018cb7ec8ab708d3961c)</a></p><h3>MolecularWeights</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>Amount</b></td></tr><tr><td style="display: none">*</td><td>exact <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> ()</span></td><td>229.26</td></tr></table><h3>Structures</h3><table class="grid"><tr><td style="display: none">-</td><td><b>MolecularFormula</b></td></tr><tr><td style="display: none">*</td><td>C8H11N303S</td></tr></table><h3>Names</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Name</b></td><td><b>Type</b></td></tr><tr><td style="display: none">*</td><td>(-)-1-((2R,5S)-2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL)CYTOSINE</td><td>Chemical Name <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (#x)</span></td></tr></table></div>
        </text>
        <identifier>
          <use value="official"/>
          <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
          <value value="2T8Q726O95"/>
        </identifier>
        <version value="1"/>
        <status>
          <coding>
            <system value="http://hl7.org/fhir/publication-status"/>
            <code value="active"/>
          </coding>
        </status>
        <manufacturer>
          <reference value="Organization/man-173fde4cb6b1018cb7ec8ab708d3961c"/>
        </manufacturer>
        <molecularWeight>
          <type>
            <text value="exact"/>
          </type>
          <amount>
            <value value="229.26"/>
          </amount>
        </molecularWeight>
        <structure>
          <molecularFormula value="C8H11N303S"/>
        </structure>
        <name>
          <name value="(-)-1-((2R,5S)-2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL)CYTOSINE"/>
          <type>
            <coding>
              <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
              <code value="x"/>
              <display value="Chemical Name"/>
            </coding>
          </type>
        </name>
      </SubstanceDefinition>
    </resource>
  </entry>
  <entry>
    <fullUrl value="http://hl7.eu/fhir/ig/gravitate-health/AdministrableProductDefinition/ap-49178f16170ee8a6bc2a4361c1748d5f"/>
    <resource>
      <AdministrableProductDefinition>
        <id value="ap-49178f16170ee8a6bc2a4361c1748d5f"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/AdministrableProductDefinition-uv-epi"/>
        </meta>
        <text>
          <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: AdministrableProductDefinition</b><a name="ap-49178f16170ee8a6bc2a4361c1748d5f"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource AdministrableProductDefinition &quot;ap-49178f16170ee8a6bc2a4361c1748d5f&quot; </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info//StructureDefinition-AdministrableProductDefinition-uv-epi.html">AdministrableProductDefinition (ePI)</a></p></div><p><b>identifier</b>: id: 123456</p><p><b>status</b>: active</p><p><b>formOf</b>: <a href="#MedicinalProductDefinition_mp16598f252d07b4784b82ba43cf9e847e">See above (MedicinalProductDefinition/mp16598f252d07b4784b82ba43cf9e847e)</a></p><p><b>administrableDoseForm</b>: tablet <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#200000002152)</span></p><p><b>unitOfPresentation</b>: tablet <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#200000002152)</span></p><p><b>producedFrom</b>: <a href="#ManufacturedItemDefinition_mid-49178f16170ee8a6bc2a4361c1748d5f">See above (ManufacturedItemDefinition/mid-49178f16170ee8a6bc2a4361c1748d5f)</a></p><blockquote><p><b>routeOfAdministration</b></p><p><b>code</b>: Oral use <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000073619)</span></p><h3>TargetSpecies</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Code</b></td></tr><tr><td style="display: none">*</td><td>Human <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000109093)</span></td></tr></table></blockquote></div>
        </text>
        <identifier>
          <system value="https://spor.ema.europa.eu/pmswi"/>
          <value value="123456"/>
        </identifier>
        <status value="active"/>
        <formOf>
          <reference value="MedicinalProductDefinition/mp16598f252d07b4784b82ba43cf9e847e"/>
        </formOf>
        <administrableDoseForm>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi"/>
            <code value="200000002152"/>
            <display value="tablet"/>
          </coding>
        </administrableDoseForm>
        <unitOfPresentation>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi"/>
            <code value="200000002152"/>
            <display value="tablet"/>
          </coding>
        </unitOfPresentation>
        <producedFrom>
          <reference value="ManufacturedItemDefinition/mid-49178f16170ee8a6bc2a4361c1748d5f"/>
        </producedFrom>
        <routeOfAdministration>
          <code>
            <coding>
              <system value="https://spor.ema.europa.eu/rmswi"/>
              <code value="100000073619"/>
              <display value="Oral use"/>
            </coding>
          </code>
          <targetSpecies>
            <code>
              <coding>
                <system value="https://spor.ema.europa.eu/rmswi"/>
                <code value="100000109093"/>
                <display value="Human"/>
              </coding>
            </code>
          </targetSpecies>
        </routeOfAdministration>
      </AdministrableProductDefinition>
    </resource>
  </entry>
  <entry>
    <fullUrl value="http://hl7.eu/fhir/ig/gravitate-health/RegulatedAuthorization/authorization49178f16170ee8a6bc2a4361c1748d5f"/>
    <resource>
      <RegulatedAuthorization>
        <id value="authorization49178f16170ee8a6bc2a4361c1748d5f"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/RegulatedAuthorization-uv-epi"/>
        </meta>
        <text>
          <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: RegulatedAuthorization</b><a name="authorization49178f16170ee8a6bc2a4361c1748d5f"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource RegulatedAuthorization &quot;authorization49178f16170ee8a6bc2a4361c1748d5f&quot; </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info//StructureDefinition-RegulatedAuthorization-uv-epi.html">RegulatedAuthorization (ePI)</a></p></div><p><b>identifier</b>: id: EU/1/19/1370/001 (use: OFFICIAL)</p><p><b>subject</b>: <a href="#MedicinalProductDefinition_mp16598f252d07b4784b82ba43cf9e847e">See above (MedicinalProductDefinition/mp16598f252d07b4784b82ba43cf9e847e)</a></p><p><b>type</b>: Marketing Authorisation <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072062)</span></p><p><b>status</b>: Active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2019-07-01 13:28:17+0000</p><p><b>holder</b>: <a href="#Organization_mah-31ff1af739c7dcf77386a86f8dd83d29">See above (Organization/mah-31ff1af739c7dcf77386a86f8dd83d29)</a></p><p><b>regulator</b>: <a href="#Organization_mra-7c9b97127f73ff3605a10eb1c2cc24d1">See above (Organization/mra-7c9b97127f73ff3605a10eb1c2cc24d1)</a></p></div>
        </text>
        <identifier>
          <use value="official"/>
          <system value="https://spor.ema.europa.eu/pmswi"/>
          <value value="EU/1/19/1370/001"/>
        </identifier>
        <subject>
          <reference value="MedicinalProductDefinition/mp16598f252d07b4784b82ba43cf9e847e"/>
        </subject>
        <type>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi"/>
            <code value="100000072062"/>
            <display value="Marketing Authorisation"/>
          </coding>
        </type>
        <status>
          <coding>
            <system value="http://hl7.org/fhir/publication-status"/>
            <code value="active"/>
            <display value="Active"/>
          </coding>
        </status>
        <statusDate value="2019-07-01T13:28:17Z"/>
        <holder>
          <reference value="Organization/mah-31ff1af739c7dcf77386a86f8dd83d29"/>
        </holder>
        <regulator>
          <reference value="Organization/mra-7c9b97127f73ff3605a10eb1c2cc24d1"/>
        </regulator>
      </RegulatedAuthorization>
    </resource>
  </entry>
  <entry>
    <fullUrl value="http://hl7.eu/fhir/ig/gravitate-health/Organization/man-173fde4cb6b1018cb7ec8ab708d3961c"/>
    <resource>
      <Organization>
        <id value="man-173fde4cb6b1018cb7ec8ab708d3961c"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Organization-uv-epi"/>
        </meta>
        <text>
          <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: Organization</b><a name="man-173fde4cb6b1018cb7ec8ab708d3961c"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Organization &quot;man-173fde4cb6b1018cb7ec8ab708d3961c&quot; </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info//StructureDefinition-Organization-uv-epi.html">Organization (ePI)</a></p></div><p><b>identifier</b>: id: ORG-100004538 (use: OFFICIAL)</p><p><b>active</b>: true</p><p><b>type</b>: Manufacturer <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#220000000033)</span></p><p><b>name</b>: GLAXO WELLCOME, S.A.</p><h3>Contacts</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Address</b></td></tr><tr><td style="display: none">*</td><td>Avda. Extremadura 3, 09400 Aranda De Duero Aranda De Duero ES(WORK)</td></tr></table></div>
        </text>
        <identifier>
          <use value="official"/>
          <system value="https://spor.ema.europa.eu/omswi"/>
          <value value="ORG-100004538"/>
        </identifier>
        <active value="true"/>
        <type>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi"/>
            <code value="220000000033"/>
            <display value="Manufacturer"/>
          </coding>
        </type>
        <name value="GLAXO WELLCOME, S.A."/>
        <contact>
          <address>
            <use value="work"/>
            <type value="physical"/>
            <text value="Avda. Extremadura 3, 09400 Aranda De Duero Aranda De Duero ES"/>
            <line value="Avda. Extremadura 3, 09400 Aranda De Duero"/>
            <city value="Aranda De Duero"/>
            <country value="ES"/>
          </address>
        </contact>
      </Organization>
    </resource>
  </entry>
  <entry>
    <fullUrl value="http://hl7.eu/fhir/ig/gravitate-health/Organization/mah-31ff1af739c7dcf77386a86f8dd83d29"/>
    <resource>
      <Organization>
        <id value="mah-31ff1af739c7dcf77386a86f8dd83d29"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Organization-uv-epi"/>
        </meta>
        <text>
          <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: Organization</b><a name="mah-31ff1af739c7dcf77386a86f8dd83d29"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Organization &quot;mah-31ff1af739c7dcf77386a86f8dd83d29&quot; </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info//StructureDefinition-Organization-uv-epi.html">Organization (ePI)</a></p></div><p><b>identifier</b>: id: ORG-100012958 (use: OFFICIAL)</p><p><b>active</b>: true</p><p><b>type</b>: Marketing authorisation holder <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#220000000034)</span></p><p><b>name</b>: ViiV Healthcare BV</p><h3>Contacts</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Address</b></td></tr><tr><td style="display: none">*</td><td>Van Asch van Wijckstraat 55H Amersfoort NL(WORK)</td></tr></table></div>
        </text>
        <identifier>
          <use value="official"/>
          <system value="https://spor.ema.europa.eu/omswi"/>
          <value value="ORG-100012958"/>
        </identifier>
        <active value="true"/>
        <type>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi"/>
            <code value="220000000034"/>
            <display value="Marketing authorisation holder"/>
          </coding>
        </type>
        <name value="ViiV Healthcare BV"/>
        <contact>
          <address>
            <use value="work"/>
            <type value="physical"/>
            <text value="Van Asch van Wijckstraat 55H Amersfoort NL"/>
            <line value="Van Asch van Wijckstraat 55H"/>
            <city value="Amersfoort"/>
            <country value="NL"/>
          </address>
        </contact>
      </Organization>
    </resource>
  </entry>
  <entry>
    <fullUrl value="http://hl7.eu/fhir/ig/gravitate-health/Organization/mra-7c9b97127f73ff3605a10eb1c2cc24d1"/>
    <resource>
      <Organization>
        <id value="mra-7c9b97127f73ff3605a10eb1c2cc24d1"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Organization-uv-epi"/>
        </meta>
        <text>
          <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: Organization</b><a name="mra-7c9b97127f73ff3605a10eb1c2cc24d1"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Organization &quot;mra-7c9b97127f73ff3605a10eb1c2cc24d1&quot; </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info//StructureDefinition-Organization-uv-epi.html">Organization (ePI)</a></p></div><p><b>identifier</b>: id: ORG-100013412 (use: OFFICIAL)</p><p><b>active</b>: true</p><p><b>type</b>: Medicines Regulatory Authority <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#220000000032)</span></p><p><b>name</b>: European Medicines Agency</p><h3>Contacts</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Address</b></td></tr><tr><td style="display: none">*</td><td>Carretera De Martorell 41 61, Poligono Industrial Nord-Est Amsterdam NL(WORK)</td></tr></table></div>
        </text>
        <identifier>
          <use value="official"/>
          <system value="https://spor.ema.europa.eu/omswi"/>
          <value value="ORG-100013412"/>
        </identifier>
        <active value="true"/>
        <type>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi"/>
            <code value="220000000032"/>
            <display value="Medicines Regulatory Authority"/>
          </coding>
        </type>
        <name value="European Medicines Agency"/>
        <contact>
          <address>
            <use value="work"/>
            <type value="physical"/>
            <text value="Carretera De Martorell 41 61, Poligono Industrial Nord-Est Amsterdam NL"/>
            <line value="Carretera De Martorell 41 61, Poligono Industrial Nord-Est"/>
            <city value="Amsterdam"/>
            <postalCode value="1083 HS"/>
            <country value="NL"/>
          </address>
        </contact>
      </Organization>
    </resource>
  </entry>
  <entry>
    <fullUrl value="http://hl7.eu/fhir/ig/gravitate-health/PackagedProductDefinition/ppd-23f4e5c6d9ca952c3ffb3940859a26f8"/>
    <resource>
      <PackagedProductDefinition>
        <id value="ppd-23f4e5c6d9ca952c3ffb3940859a26f8"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/PackagedProductDefinition-uv-epi"/>
        </meta>
        <text>
          <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: PackagedProductDefinition</b><a name="ppd-23f4e5c6d9ca952c3ffb3940859a26f8"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource PackagedProductDefinition &quot;ppd-23f4e5c6d9ca952c3ffb3940859a26f8&quot; </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info//StructureDefinition-PackagedProductDefinition-uv-epi.html">PackagedProductDefinition (ePI)</a></p></div><p><b>identifier</b>: id: EU/1/19/1370/001 (use: OFFICIAL)</p><p><b>name</b>: 50 mg/300 mg film-coated tablets</p><p><b>type</b>: Chemical Medicinal Prodcut <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000155527)</span></p><p><b>packageFor</b>: <a href="#MedicinalProductDefinition_mp16598f252d07b4784b82ba43cf9e847e">See above (MedicinalProductDefinition/mp16598f252d07b4784b82ba43cf9e847e)</a></p><p><b>status</b>: Active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2012-02-07 13:28:17+0000</p><p><b>containedItemQuantity</b>: 30 {tablets}<span style="background: LightGoldenRodYellow"> (Details: UCUM code {tablets} = '{tablets}')</span></p><p><b>manufacturer</b>: <a href="#Organization_man-173fde4cb6b1018cb7ec8ab708d3961c">See above (Organization/man-173fde4cb6b1018cb7ec8ab708d3961c)</a></p><blockquote><p><b>packaging</b></p><p><b>type</b>: Box <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000073498)</span></p><p><b>quantity</b>: 1</p><p><b>material</b>: Cardboard <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#200000003529)</span></p><blockquote><p><b>packaging</b></p><p><b>identifier</b>: id: 654321</p><p><b>type</b>: Child-resistant closure <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000073504)</span></p><p><b>quantity</b>: 1</p><p><b>material</b>: Cardboard <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#200000003529)</span></p><blockquote><p><b>containedItem</b></p></blockquote></blockquote></blockquote></div>
        </text>
        <identifier>
          <use value="official"/>
          <system value="https://spor.ema.europa.eu/pmswi"/>
          <value value="EU/1/19/1370/001"/>
        </identifier>
        <name value="50 mg/300 mg film-coated tablets"/>
        <type>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi"/>
            <code value="100000155527"/>
            <display value="Chemical Medicinal Prodcut"/>
          </coding>
        </type>
        <packageFor>
          <reference value="MedicinalProductDefinition/mp16598f252d07b4784b82ba43cf9e847e"/>
        </packageFor>
        <status>
          <coding>
            <system value="http://hl7.org/fhir/publication-status"/>
            <code value="active"/>
            <display value="Active"/>
          </coding>
        </status>
        <statusDate value="2012-02-07T13:28:17Z"/>
        <containedItemQuantity>
          <value value="30"/>
          <system value="http://unitsofmeasure.org"/>
          <code value="{tablets}"/>
        </containedItemQuantity>
        <manufacturer>
          <reference value="Organization/man-173fde4cb6b1018cb7ec8ab708d3961c"/>
        </manufacturer>
        <packaging>
          <type>
            <coding>
              <system value="https://spor.ema.europa.eu/rmswi"/>
              <code value="100000073498"/>
              <display value="Box"/>
            </coding>
          </type>
          <quantity value="1"/>
          <material>
            <coding>
              <system value="https://spor.ema.europa.eu/rmswi"/>
              <code value="200000003529"/>
              <display value="Cardboard"/>
            </coding>
          </material>
          <packaging>
            <identifier>
              <system value="https://spor.ema.europa.eu/pmswi"/>
              <value value="654321"/>
            </identifier>
            <type>
              <coding>
                <system value="https://spor.ema.europa.eu/rmswi"/>
                <code value="100000073504"/>
                <display value="Child-resistant closure"/>
              </coding>
            </type>
            <quantity value="1"/>
            <material>
              <coding>
                <system value="https://spor.ema.europa.eu/rmswi"/>
                <code value="200000003529"/>
                <display value="Cardboard"/>
              </coding>
            </material>
            <containedItem>
              <item>
                <reference>
                  <reference value="ManufacturedItemDefinition/mid-49178f16170ee8a6bc2a4361c1748d5f"/>
                </reference>
              </item>
            </containedItem>
          </packaging>
        </packaging>
      </PackagedProductDefinition>
    </resource>
  </entry>
  <entry>
    <fullUrl value="http://hl7.eu/fhir/ig/gravitate-health/MedicinalProductDefinition/mp16598f252d07b4784b82ba43cf9e847e"/>
    <resource>
      <MedicinalProductDefinition>
        <id value="mp16598f252d07b4784b82ba43cf9e847e"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/MedicinalProductDefinition-uv-epi"/>
        </meta>
        <text>
          <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: MedicinalProductDefinition</b><a name="mp16598f252d07b4784b82ba43cf9e847e"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource MedicinalProductDefinition &quot;mp16598f252d07b4784b82ba43cf9e847e&quot; </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info//StructureDefinition-MedicinalProductDefinition-uv-epi.html">MedicinalProductDefinition (ePI)</a></p></div><p><b>identifier</b>: id: EU/1/19/1370/001, id: 0x073AF2E5B92AE19E8B67635AFFB3D6CA</p><p><b>type</b>: Medicinal Product <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-medicinal-product-type.html">Medicinal Product Type</a>#MedicinalProduct)</span></p><p><b>domain</b>: Human use <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-medicinal-product-domain.html">Medicinal Product Domain</a>#Human)</span></p><p><b>status</b>: active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>legalStatusOfSupply</b>: Medicinal product subject to medical prescription <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072084)</span></p><blockquote><p><b>name</b></p><p><b>productName</b>: Dovato 50 mg/300 mg film-coated tablets</p><p><b>type</b>: Full name <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (220000000000#220000000001)</span></p><blockquote><p><b>part</b></p><p><b>part</b>: Dovato</p><p><b>type</b>: Invented name part <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (220000000000#220000000002)</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: dolutegravir/lamivudine</p><p><b>type</b>: Scientific name part <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (220000000000#220000000003)</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: 50 mg/300 mg</p><p><b>type</b>: Strength part <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (220000000000#220000000004)</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: film-coated tablets</p><p><b>type</b>: Pharmaceutical dose form part <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (220000000000#220000000005)</span></p></blockquote><h3>Usages</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Country</b></td><td><b>Jurisdiction</b></td><td><b>Language</b></td></tr><tr><td style="display: none">*</td><td>United Kingdom <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-ISO3166Part1.html">ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code</a>#GBR)</span></td><td>United Kingdom <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-ISO3166Part1.html">ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code</a>#GBR)</span></td><td>English <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-v3-ietf3066.html">Tags for the Identification of Languages</a>#en)</span></td></tr></table></blockquote></div>
        </text>
        <identifier>
          <system value="https://spor.ema.europa.eu/pmswi"/>
          <value value="EU/1/19/1370/001"/>
        </identifier>
        <identifier>
          <system value="https://www.who-umc.org/phpid"/>
          <value value="0x073AF2E5B92AE19E8B67635AFFB3D6CA"/>
        </identifier>
        <type>
          <coding>
            <system value="http://hl7.org/fhir/medicinal-product-type"/>
            <code value="MedicinalProduct"/>
            <display value="Medicinal Product"/>
          </coding>
        </type>
        <domain>
          <coding>
            <system value="http://hl7.org/fhir/medicinal-product-domain"/>
            <code value="Human"/>
            <display value="Human use"/>
          </coding>
        </domain>
        <status>
          <coding>
            <system value="http://hl7.org/fhir/publication-status"/>
            <code value="active"/>
            <display value="active"/>
          </coding>
        </status>
        <legalStatusOfSupply>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi"/>
            <code value="100000072084"/>
            <display value="Medicinal product subject to medical prescription"/>
          </coding>
        </legalStatusOfSupply>
        <name>
          <productName value="Dovato 50 mg/300 mg film-coated tablets"/>
          <type>
            <coding>
              <system value="https://spor.ema.europa.eu/lists/220000000000"/>
              <code value="220000000001"/>
              <display value="Full name"/>
            </coding>
          </type>
          <part>
            <part value="Dovato"/>
            <type>
              <coding>
                <system value="https://spor.ema.europa.eu/lists/220000000000"/>
                <code value="220000000002"/>
                <display value="Invented name part"/>
              </coding>
            </type>
          </part>
          <part>
            <part value="dolutegravir/lamivudine"/>
            <type>
              <coding>
                <system value="https://spor.ema.europa.eu/lists/220000000000"/>
                <code value="220000000003"/>
                <display value="Scientific name part"/>
              </coding>
            </type>
          </part>
          <part>
            <part value="50 mg/300 mg"/>
            <type>
              <coding>
                <system value="https://spor.ema.europa.eu/lists/220000000000"/>
                <code value="220000000004"/>
                <display value="Strength part"/>
              </coding>
            </type>
          </part>
          <part>
            <part value="film-coated tablets"/>
            <type>
              <coding>
                <system value="https://spor.ema.europa.eu/lists/220000000000"/>
                <code value="220000000005"/>
                <display value="Pharmaceutical dose form part"/>
              </coding>
            </type>
          </part>
          <usage>
            <country>
              <coding>
                <system value="urn:iso:std:iso:3166"/>
                <code value="GBR"/>
                <display value="United Kingdom"/>
              </coding>
            </country>
            <jurisdiction>
              <coding>
                <system value="urn:iso:std:iso:3166"/>
                <code value="GBR"/>
                <display value="United Kingdom"/>
              </coding>
            </jurisdiction>
            <language>
              <coding>
                <system value="urn:ietf:bcp:47"/>
                <code value="en"/>
                <display value="English"/>
              </coding>
            </language>
          </usage>
        </name>
      </MedicinalProductDefinition>
    </resource>
  </entry>
  <entry>
    <fullUrl value="http://hl7.eu/fhir/ig/gravitate-health/ManufacturedItemDefinition/mid-49178f16170ee8a6bc2a4361c1748d5f"/>
    <resource>
      <ManufacturedItemDefinition>
        <id value="mid-49178f16170ee8a6bc2a4361c1748d5f"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ManufacturedItemDefinition-uv-epi"/>
        </meta>
        <text>
          <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: ManufacturedItemDefinition</b><a name="mid-49178f16170ee8a6bc2a4361c1748d5f"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource ManufacturedItemDefinition &quot;mid-49178f16170ee8a6bc2a4361c1748d5f&quot; </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info//StructureDefinition-ManufacturedItemDefinition-uv-epi.html">ManufacturedItemDefinition (ePI)</a></p></div><p><b>identifier</b>: id: EU/1/19/1370/001 (use: OFFICIAL)</p><p><b>status</b>: active</p><p><b>manufacturedDoseForm</b>: Film-coated tablet <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (#100000073665)</span></p><p><b>unitOfPresentation</b>: Tablet <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#200000002152)</span></p><p><b>manufacturer</b>: <a href="#Organization_man-173fde4cb6b1018cb7ec8ab708d3961c">See above (Organization/man-173fde4cb6b1018cb7ec8ab708d3961c)</a></p></div>
        </text>
        <identifier>
          <use value="official"/>
          <system value="https://spor.ema.europa.eu/pmswi"/>
          <value value="EU/1/19/1370/001"/>
        </identifier>
        <status value="active"/>
        <manufacturedDoseForm>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi/"/>
            <code value="100000073665"/>
            <display value="Film-coated tablet"/>
          </coding>
        </manufacturedDoseForm>
        <unitOfPresentation>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi"/>
            <code value="200000002152"/>
            <display value="Tablet"/>
          </coding>
        </unitOfPresentation>
        <manufacturer>
          <reference value="Organization/man-173fde4cb6b1018cb7ec8ab708d3961c"/>
        </manufacturer>
      </ManufacturedItemDefinition>
    </resource>
  </entry>
</Bundle>